Precocious puberty and Injection site abscess

Summary:

Injection site abscess is found among people with Precocious puberty, especially for people who are female, 2-9 old.

The study analyzes which people have Injection site abscess with Precocious puberty. It is created by eHealthMe based on reports of 95 people who have Precocious puberty from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Precocious puberty?

Precocious puberty is found to be associated with 40 drugs and 172 conditions by eHealthMe. Check the latest studies of Precocious puberty.

What is Injection site abscess?

Injection site abscess is found to be associated with 199 drugs and 358 conditions by eHealthMe. Check the latest studies of Injection site abscess.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 29, 2026

95 people who have Precocious Puberty and Injection Site Abscess are studied.

Would you have Injection site abscess when you have Precocious puberty?

Gender of people who have Precocious Puberty and experienced Injection Site Abscess *:

  • female: 90.48 %
  • male: 9.52 %

Age of people who have Precocious Puberty and experienced Injection Site Abscess *:

  • 0-1: 0.0 %
  • 2-9: 65.28 %
  • 10-19: 34.72 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Sleep Disorder: 1 person, 1.05%
  2. Low Density Lipoprotein Increased (cholesterol increased in blood): 1 person, 1.05%
  3. Indigestion: 1 person, 1.05%
  4. Hypersensitivity: 1 person, 1.05%
  5. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 1.05%
  6. High Blood Pressure: 1 person, 1.05%
  7. Growth Hormone Deficiency: 1 person, 1.05%
  8. Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 1 person, 1.05%
  9. Diabetes: 1 person, 1.05%
  10. Chest Pain: 1 person, 1.05%

Common drugs taken by these people *:

  1. Lupron Depot-Ped: 33 people, 34.74%
  2. Lupron Depot: 13 people, 13.68%
  3. Eligard: 11 people, 11.58%
  4. Leuprolide Acetate: 6 people, 6.32%
  5. Lupron: 6 people, 6.32%
  6. Zyrtec: 3 people, 3.16%
  7. Albuterol: 2 people, 2.11%
  8. Clonidine: 2 people, 2.11%
  9. Concerta: 2 people, 2.11%
  10. Furosemide: 1 person, 1.05%

Common symptoms for these people *:

  1. Injection Site Pain: 20 people, 21.05%
  2. Injection Site Erythema (redness at injection site): 17 people, 17.89%
  3. Injection Site Swelling: 11 people, 11.58%
  4. Injection Site Mass: 6 people, 6.32%
  5. Injection Site Induration: 6 people, 6.32%
  6. Impaired Healing: 5 people, 5.26%
  7. Drug Ineffective: 5 people, 5.26%
  8. Injection Site Inflammation: 4 people, 4.21%
  9. Injection Site Haemorrhage (bleeding from injection site): 4 people, 4.21%
  10. Injection Site Warmth: 4 people, 4.21%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Injection site abscess?

- Check whether Injection site abscess is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Injection site abscess:

All the conditions that are associated with Injection site abscess:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Injection site abscess and Precocious puberty, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: